SCHEMBL22019710

SCHEMBL22019710

Cc1c(C2CC2)nc2c(c1C)CCC2C

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 2/20 0.40
HRH3 Q9Y5N1 2/20 0.40
PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22282198 0.86 HRH3 (0.38) HRH2HRH3
SCHEMBL21963095 0.84 HRH3 (0.44) HRH2HRH3PDE10A
SCHEMBL31475643 0.84 HRH3 (0.44) HRH2HRH3PDE10A
SCHEMBL24977997 0.81 HRH2 (0.36) HRH2HRH3
SCHEMBL24978154 0.75 HRH2 (0.40) HRH2HRH3
SCHEMBL21963378 0.72 HRH3 (0.43) HRH2HRH3
SCHEMBL24978304 0.71 HRH3 (0.44) HRH2HRH3
SCHEMBL22019718 0.70 HRH3 (0.38) HRH2HRH3
SCHEMBL22020826 0.70 HRH3 (0.38) HRH2HRH3
SCHEMBL22021272 0.70 HRH3 (0.38) HRH2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020154499-A1 SULFONIMIDAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-07-30 WO disclosed
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed